logo-loader
viewIQ-AI Limited

IQ-AI on track to double sales in 2019 as it inks deal with CorTechs Labs

IQ-AI Limited’s (LON:IQAI) David Smith caught up with Proactive London's Andrew Scott after announcing that Imaging Biometrics has signed a non-exclusive business development and sales deal with brain analysis firm CorTechs Labs.

Smith says the deal gives them extended and immediate sales representation in the US and other international markets.

He adds that product sales have continued to accelerate in 2019 and as a result they're expecting full year 2019 numbers to be more than double those for 2018.

Quick facts: IQ-AI Limited

Price: 5.55 GBX

LSE:IQAI
Market: LSE
Market Cap: £7.76 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IQ-AI Limited named herein, including the promotion by the Company of IQ-AI Limited in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: FDA StoneChecker clearance a 'validation and tremendous leap...

IQ-AI Limited's (LON:IQAI) David Smith says the focus of their work on StoneChecker's moved into the commercial phase following FDA clearance for the product in the US. The software helps to identify the patients who would respond best to lithotripsy, which breaks up kidney stones using sound...

on 1/10/19

2 min read